Abstract:Background Throughout the world, diabetic nephropathy has been treated by managing hyperglycemia and hypertension with antidiabetic and antihypertensive drugs, but the potency of reversing the diabetic nephropathy-induced complications is still questionable. Materials and Methods This study was focused on elucidating the nephroprotective effect of purpurin, a natural anthraquinone, against diabetic nephropathy induced in an in vivo model. Diabetic nephropathy was induced in rats by injecting streptozotocin (STZ) and then treating them with purpurin. The rats were analyzed for food intake, body weight gain, fasting blood glucose (FBG), glycated hemoglobin (HbA1C), serum insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) to analyze the anti-glycemic effect of purpurin on diabetic nephropathy-induced rats. The lipid profile, blood urea nitrogen (BUN), serum creatinine, and lactate dehydrogenase (LDH), and kidney injury molecule-1 (KIM-1) levels were assessed. Proinflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and interleukin 6 (IL-6), were quantified to determine the anti-inflammatory effect of purpurin on diabetic nephropathy-induced rats. Finally, histopathological analysis of kidney tissue was performed. Results Purpurin effectively decreased the body weight, FBG, HbA1C, HOMA-IR values, and increased insulin levels. It significantly decreased lipid profiles while increasing high-density lipoprotein (HDL) in diabetic nephropathy-induced rats. It also decreased the BUN, creatinine, LDH, and KIM-1 levels. The reduction in proinflammatory cytokine levels was observed in the purpurin-treated diabetic nephropathy rats. Finally, the histopathological analysis confirms the nephroprotective effect of purpurin. Conclusion Taken together, our results conclude that purpurin possesses therapeutic potency to ameliorate diabetic-induced nephropathy, and it can be a promising drug for diabetic nephropathy in the future.

Alizarin and Purpurin from Rubia Tinctorum L. Suppress Insulin Fibrillation and Reduce the Amyloid-Induced Cytotoxicity

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Effects of Several Quinones on Insulin Aggregation

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

A Redox Cycle Meets Insulin Fibrillation in Vitro.

Fluorescent Silicon Nanoparticles Inhibit the Amyloid Fibrillation of Insulin

In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions

Inhibition of amyloidal aggregation of insulin by amino acid conjugated bile acids: An insight into the possible role of biosurfactants in modulating the fibrillation kinetics and cytotoxicity

Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives

Dissecting the role of disulfide bonds on the amyloid formation of insulin.

Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation.

Exploration of Isoquinoline Alkaloids As Potential Inhibitors Against Human Islet Amyloid Polypeptide

Triterpenoids impede the fibrillation and cytotoxicity of human islet amyloid polypeptide

Rutin Inhibits Amylin-Induced Neurocytotoxicity and Oxidative Stress.

Procyanidine Resists the Fibril Formation of Human Islet Amyloid Polypeptide.

Vanillin Affects Amyloid Aggregation and Non-Enzymatic Glycation in Human Insulin

Purpurin, a Natural Anthroquinone Ameliorates Streptozotocin-induced Diabetic Nephropathy via Attenuating Hyperglycemia, Dyslipidemia, and Inflammation in Rats

Quinoline yellow acts as a novel amyloid fibrillation probe by using surface-enhanced Raman spectroscopy

Efficient inhibition of amyloid fibrillation and cytotoxicity of α-synuclein and human insulin using biosynthesized silver nanoparticles decorated by green tea polyphenols

Inhibition of Human Amylin Fibril Formation by Insulin-Mimetic Vanadium Complexes

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.